🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess the safety and tolerability of zipra...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2006-06
Trial ID
NCT00265382
Treatments Being Tested
The purpose of this study is to determine if flexibly-dosed ziprasidone is ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-01
Trial ID
NCT00257166
Treatments Being Tested
The purpose of this study is to determine if ziprasidone is safe and effect...
Status
Terminated
Location
Harmonex Neuroscience Research, Inc.
Start Date
2014-05-23
Trial ID
NCT02075047
Treatments Being Tested
To assess the efficacy, safety, and tolerability of intramuscular ziprasido...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2003-07
Trial ID
NCT00644800
Treatments Being Tested
This study uses polysomnographs(PSG) to investigate sleep patterns in patie...
Status
Completed
Location
Providence Care Mental Health Services
Start Date
2009-02
Trial ID
NCT00835107
Treatments Being Tested
The purpose of this study is to determine if ziprasidone plus a mood stabil...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2005-12
Trial ID
NCT00280566
Treatments Being Tested
The primary aims of this study are to assess tolerability of ziprasidone do...
Status
Completed
Location
Medical College of Georgia
Start Date
2006-01
Trial ID
NCT00403546
Treatments Being Tested
The purpose of this study is to determine if a treatment regimen of ziprasi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2007-10
Trial ID
NCT00483548
Treatments Being Tested
The purpose of this study is to determine if flexibly-dosed ziprasidone is ...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2006-04
Trial ID
NCT00257192
Treatments Being Tested
The purpose of this study is to assess the safety and tolerability of zipra...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-03
Trial ID
NCT00265330
Treatments Being Tested